Zymeworks BC Inc
ZYME
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.9B
Close$
$-19.42
177.9% downside
Current Fair Value
177.9% downsideOvervalued by 177.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.90 Billion |
|---|---|
| Enterprise Value | $-223,191,906,407.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.08 |
| Beta | 1.13 |
| Outstanding Shares | 74,669,000 |
Return
| Return on Equity | -39.00% |
|---|---|
| Return on Assets | -13.34% |
| Return on Invested Capital | -15.65% |
Valuation & Multiples
| P/E Ratio | -18.9 |
|---|---|
| PEG | -0.01 |
| Price to Sales | - |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | -4355.73 |
| Enterprise Value to EBIT | 3.22 |
| Enterprise Value to Net Income | 3 |
| Total Debt to Enterprise | -0.09 |
| Debt to Equity | 0.12 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-0.10
Average shareholder expectationRevenue Estimate
$24.37 M
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-0.39
Average shareholder expectationRevenue Estimate
$19.10 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 12.72% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.83%▼ 91.46% |
|---|---|
| Total Invested | $35.78M▼ 97.97% |
| Investors Holding | 5▼ 216.00% |
ESG Score
No data
About Zymeworks Inc
CEO: Ali Tehrani